Furthermore, it is crucial to identify the specific functional peptide of apoA-IV that plays a role in modulating glucose homeostasis, which would potentially offer therapeutic benefits in managing obesity and T2D. This evidence concerns the gene APOA4 and type 2 diabetes mellitus.